Of the two other genes indicated as direct, downregulated targets for miR-32, namely Pck1 and Pdk4 (Supplementary Table 1), Pck1 is not expressed in prostate tumors of patients (data not shown) and thus it is also unlikely to represent a clinically relevant miR-32 target in PC. Here, PDK4 is linked to prostate neoplasm.